# Botulinum Toxins Intralesional Injection for Scar Pain

> **NCT03982862** · PHASE4 · UNKNOWN · sponsor: **Kaohsiung Medical University** · enrollment: 20 (estimated)

## Conditions studied

- Scar Keloid
- Hypertrophic Scar

## Interventions

- **DRUG:** Triamcinolone
- **DRUG:** Lidocaine
- **DRUG:** Botulinum toxin A

## Key facts

- **NCT ID:** NCT03982862
- **Lead sponsor:** Kaohsiung Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-30
- **Primary completion:** 2019-06-30
- **Final completion:** 2019-06-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2019-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03982862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03982862, "Botulinum Toxins Intralesional Injection for Scar Pain". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03982862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*